Edition:
India

STERIS plc (STE.N)

STE.N on New York Stock Exchange

111.96USD
1:32am IST
Change (% chg)

$0.65 (+0.58%)
Prev Close
$111.31
Open
$111.28
Day's High
$112.08
Day's Low
$111.04
Volume
79,327
Avg. Vol
101,472
52-wk High
$112.08
52-wk Low
$81.57

Summary

Name Age Since Current Position

Jack Wareham

76 Chairman of the Board

Walter Rosebrough

64 2007 President, Chief Executive Officer, Director

Michael Tokich

49 2017 Chief Financial Officer, Senior Vice President

Kathleen Bardwell

61 2014 Chief Operating Officer, Senior Vice President

Michiel de Zwaan

46 2017 Chief Human Resource Officer, Vice President

Daniel Carestio

45 2018 Senior Vice President - Sterilization and Disinfection

Adrian Coward

48 2015 Senior Vice President - Healthcare Specialty Services

Gulam Khan

51 2015 Senior Vice President - Procedural Solutions

Sudhir Pahwa

65 2014 Senior Vice President - Infection Prevention Technologies

Karen Burton

50 2017 Chief Accounting Officer, Vice President, Controller

J. Adam Zangerle

51 2013 Vice President, General Counsel, Secretary

Renato Tamaro

49 2017 Vice President, Corporate Treasurer

Bruce Edwards

62 Director

Kevin McMullen

56 Director

Richard Breeden

68 2008 Independent Director

Cynthia Feldmann

65 2005 Independent Director

Jacqueline Kosecoff

68 2003 Independent Director

David Lewis

73 2010 Independent Director

Duncan Nichol

77 2015 Independent Director

Nirav Shah

46 2018 Independent Director

Mohsen Sohi

59 2005 Independent Director

Richard Steeves

56 2015 Independent Director

Loyal Wilson

70 1987 Independent Director

Michael Wood

74 2004 Independent Director

Julie Winter

2018 IR Contact Officer

Biographies

Name Description

Jack Wareham

Walter Rosebrough

Mr. Walter M. Rosebrough, Jr. is President, Chief Executive Officer of the Company. He assumed this role when he joined STERIS in October 2007. Mr. Rosebrough is a Director of Varex Imaging Corporation.

Michael Tokich

Mr. Michael J. Tokich is Chief Financial Officer, Senior Vice President of the Company. From February 2014 to July 2017, he served as the Senior Vice President, Chief Financial Officer and Treasurer. From March 2008 to February 2014, he served as Senior Vice President and Chief Financial Officer.

Kathleen Bardwell

Mrs. Kathleen L. Bardwell is Chief Operating Officer, Senior Vice President of the Company. She assumed this role in February 2014. From March 2008 to February 2014, she served as Vice President, Chief Compliance Officer. Mrs. Bardwell is a Director of First Financial Bancorp.

Michiel de Zwaan

Mr. Michiel de Zwaan is Chief Human Resource Officer, Vice President of the Company. He assumed this role in September 2017. He served as Senior Vice President and Chief Human Resources Officer at Hill-Rom Inc. from August 2014 through December 2015, and as Vice President of Human Resources, International, at Hill-Rom Europe B.V. from September 2011 through July 2014.

Daniel Carestio

Mr. Daniel A. Carestio is Senior Vice President - Sterilization and Disinfection of the Company. He assumed this role in February 2018. From August 2015 to February 2018, he served as Senior Vice President, STERIS Applied Sterilization Technologies and Life Sciences. From 2011 to August 2015, he served as Vice President, Sales and Marketing for Isomedix Services and General Manager of Life Sciences.

Adrian Coward

Dr. Adrian Coward is Senior Vice President - Healthcare Specialty Services of the Company. He assumed this role in November 2015. From April 2014 to November 2015, he served as Chief Operating Officer of Synergy Health plc. From April 2010 to March 2014, Dr. Coward served as CEO of UK & Ireland of Synergy Health plc.

Gulam Khan

Mr. Gulam A. Khan is Senior Vice President - Procedural Solutions of the Company. He assumed this role in August 2015. He served as Chief Executive Officer of United States Endoscopy Group, Inc. from January 2003, prior to its acquisition by STERIS in August 2012, remaining with STERIS until June 2013. From April 2014 until August 2015, he provided independent consulting services to corporations, including business integration consulting services to STERIS.

Sudhir Pahwa

Mr. Sudhir K. Pahwa is Senior Vice President - Infection Prevention Technologies of the Company. He assumed this role in February 2014. From December 2008 to February 2014, he served as Vice President and General Manager, Infection Prevention Technologies.

Karen Burton

Ms. Karen L. Burton is Chief Accounting Officer, Vice President, Controller of the company effective January 26, 2017. she joined STERIS Corporation, now a subsidiary of the Company, in September of 2004 and has served as STERIS Corporation’s Vice President, Corporate Controller from May, 2008 to the present.

J. Adam Zangerle

Mr. J. Adam Zangerle is Vice President, General Counsel, Secretary of the Company. He assumed this role in July 2013. From May 2007 to July 2013 he served as Associate General Counsel and Group General Counsel, Healthcare.

Renato Tamaro

Mr. Renato G. Tamaro is Vice President, Corporate Treasurer of the Company. He assumed this role in August 2017. From March 2006 to July 2017, he served as Assistant Treasurer.

Bruce Edwards

Kevin McMullen

Richard Breeden

Mr. Richard C. Breeden is Independent Director of the Company. Mr. Breeden, director since April 2008, and Chairman and Chief Executive Officer of Breeden Capital Management LLC, a registered investment advisor, since 2005. Since 1996 he has also been Chairman of Richard C. Breeden & Co., LLC, a professional services firm providing consulting services. From time to time Mr. Breeden also handles asset distributions to victims of unlawful conduct, typically on behalf of U.S. Government agencies. Since late 2012, Mr. Breeden has served as Special Master on behalf of the U.S. Department of Justice to administer and distribute just over $4 billion in forfeited assets to victims of the fraud at Madoff Securities through the Madoff Victim Fund. Mr. Breeden is currently handling distributions of Fair Funds aggregating over $700 million for the SEC in cases involving British Petroleum’s disclosures involving the oil spill in the Gulf of Mexico, and J.P. Morgan’s disclosures involving the so-called “London Whale,” and a case involving certain mortgage backed securities sold by Citicorp. Mr. Breeden has previously handled asset distributions to victims of unlawful conduct at WorldCom, Enron, Adelphia, Royal Dutch Shell, and other companies. Mr. Breeden served as Chairman of the SEC from 1989 to 1993. Mr. Breeden currently also serves on the Standing Advisory Group of the Public Company Accounting Oversight Board.

Cynthia Feldmann

Ms. Cynthia L. Feldmann, CPA., is Independent Director of the Company. Ms. Feldmann, director since March 2005 and President and Founder of Jetty Lane Associates, a consulting firm, from December 2005 to December 2011. Ms. Feldmann is a retired certified public accountant with 27 years of experience in two large global accounting firms. From 2003 to 2005, Ms. Feldmann served as the Life Sciences Business Development Officer for the Boston law firm Palmer & Dodge, LLP. From 1994 to 2002, Ms. Feldmann was a partner with KPMG LLP, primarily serving as Partner-in-Charge of its National Medical Technologies Practice. From 1975 to 1994, Ms. Feldmann was employed by Coopers & Lybrand (now PricewaterhouseCoopers LLP), and during that time was named Partner-in-Charge of its Life Sciences practice. Ms. Feldmann has a Bachelor of Science, Accounting, and holds a Master Professional Director Certification from the American College of Corporate Directors. From March 2012 to August 2016, Ms. Feldmann served as a director of HeartWare International, Inc. Ms. Feldmann served as a director of Hanger, Inc. until January 2018. Ms. Feldmann is a director of UFP Technologies, Inc.

Jacqueline Kosecoff

Dr. Jacqueline B. Kosecoff is Independent Director of the Company. Dr. Kosecoff, age 68, director since October 2003 and, since March 2012, Managing Partner, Moriah Partners, LLC, a private equity firm focused on health services and technology, and Senior Advisor to Warburg Pincus LLC, a private equity fund. She also has served as a member of the Executive Advisory Board of SAP America, Inc., a software and enterprise applications provider, from November 2010 through May, 2017. From October 2007 to November 2011, Dr. Kosecoff served as Chief Executive Officer of OptumRx (formerly named Prescriptions Solutions), a pharmacy benefits management company and subsidiary of UnitedHealth Group, and continued to serve as a senior advisor to OptumRx from December 2011 to February 2012. Dr. Kosecoff served as Chief Executive Officer of Ovations Pharmacy Solutions, a UnitedHealth Group company, from December 2005 to October 2007. From July 2002 to December 2005, Dr. Kosecoff served as Executive Vice President, Specialty Companies, of PacifiCare Health Systems, Inc., one of the nation’s largest consumer health organizations. From 1998 to 2002, Dr. Kosecoff was President and Founder of Protocare, Inc., a firm involved in the development and testing of drugs, devices, biopharmaceutical and nutritional products, and consulting and analytic services. Dr. Kosecoff is a director of Sealed Air Corporation, athenahealth, Inc., and Houlihan Lokey.

David Lewis

Mr. David B. Lewis is Independent Director of the Company. Mr. Lewis is director since July 2010 and of counsel with Lewis & Munday since August 1, 2014, a Detroit based law firm with offices in Washington, D.C. and New York, NY. He was a partner in the firm from its creation in 1972 to August 2014, specializing in the issuance of municipal bonds for states and local governments. He served as its President and Chief Executive Officer from 1972 to 1982 and its Chairman and Chief Executive Officer from 1982 to January 2011. He is a director of H&R Block, Inc. Previously, Mr. Lewis served on the Boards of Conrail, Inc., LG&E Energy Corp., M.A. Hanna, TRW, Inc., The Kroger Company, and Comerica, Inc. Mr. Lewis is a member of the committee which governs the UAW Retiree Medical Benefits Trust, a voluntary employee benefits trust which delivers medical/health benefits to retired employees of Fiat Chrysler, Ford, and General Motors and also chairs the audit subcommittee of the trust.

Duncan Nichol

Sir Duncan K. Nichol is Independent Director of the Company. In connection with the closing of the Combination in November 2015, Sir Duncan Nichol resigned as Chairman of Synergy Health plc, a provider of specialty outsourced services to healthcare related industries, a position he had held since June 2012. Sir Duncan Nichol also has served from November 2012 to the present as Chairman of the Countess of Chester NHS Trust, a general acute hospital, from 2004 to the present as a director of Deltex Medical Group plc, a medical technology company, and from 2009 to the present as a director of United Kingdom Accreditation Services, the national ISO standards accreditation and certification body. Sir Duncan Nichol was previously Chief Executive Officer of the NHS Management Executive between December 1989 and March 1994, and a director of the Christie NHS Foundation Trust between April 2008 and October 2012.

Nirav Shah

Dr. Nirav R. Shah is Independent Director of the Company. Dr. Shah began serving as Senior Scholar at the Clinical Excellence Research Center at Stanford University in May 2018. Previously Dr. Shah served as Commissioner of Health of the State of New York from January 2011 to May 2014 and as Senior Vice President and Chief Operating Officer for Clinical Operations for Kaiser Permanente Southern California from May 2014 to October 2017. Between October 2017 and May 2018, Dr. Shah was self-employed as a healthcare industry consultant.

Mohsen Sohi

Dr. Mohsen M. Sohi is Independent Director of the Company since July 2005, and since July 2012, Chief Executive Officer of Freudenberg and Co., a general multi-industry company serving industries that include automotive, medical, aerospace, oil and gas, and power generation and transmission. From July 2010 to June 2012, Dr. Sohi served as Managing Partner of Freudenberg and Co. From March 2003 through June 2010, Dr. Sohi served as President and Chief Executive Officer of Freudenberg-NOK, a privately-held joint venture partnership between Freudenberg and NOK Corp. of Japan, one of the world’s largest producers of elastomeric seals and custom molded products for automotive and other applications. From January 2001 to March 2003, Dr. Sohi was with NCR Corporation, a leading global technology company, most recently as the Senior Vice President, Retail Solutions Division. Prior to NCR, Dr. Sohi was with Honeywell International Inc. and its pre-merger constituent, Allied Signal, Inc., providers of aerospace, automation and control solutions, specialty materials, and transportation systems, for 14 years, serving from July 2000 to January 2001 as President, Honeywell Electronic Materials. Dr. Sohi previously served as a director of Aviat Networks, Inc. (formerly known as Harris Stratex Networks, Inc.) from 2007 until January 2015 and Hayes Lemmerz International from 2004 until 2009. Mr. Sohi serves as a member of the Supervisory Board of ZF Friedrichschafen AG.

Richard Steeves

Dr. Richard Martin Steeves, Ph.D., is Independent Director of the Company, since November 2015. In connection with the closing of the Combination in November 2015, Dr. Steeves resigned as Chief Executive Officer and director of Synergy Health plc, a provider of specialty outsourced services to the healthcare and related industries, a position he had held since 1992. Dr. Steeves also served as non-executive Chairman of Toumaz plc, a semiconductor company focusing on digital radio, connected audio and wireless healthcare, between September 2013 and May 2015. Dr. Steeves has served since January 2018 as a director of Gama Aviation plc, since July 2017 as Executive Chairman of Advanced Research Cryptography Ltd and since April 2018 as Nonexecutive Chairman of Future Health Works.

Loyal Wilson

Mr. Loyal W. Wilson is Independent Director of the Company, since 1987. In December 2016, Mr. Wilson retired as Founder and Senior Advisor of Primus Capital Partners, Inc., a private equity firm specializing in value added investments in growth oriented companies in the healthcare, software/technology and technology enabled business services industries with a specific focus in healthcare IT, healthcare services, financial technology, marketing technology, education technology and human capital management. Mr. Wilson served as a Managing Director of Primus Capital Partners, Inc. from its formation in 1994 to December 2016. Mr. Wilson formerly served as a Managing Partner of Primus Venture Partners, L.P. a venture capital and private equity firm which he founded in 1983.

Michael Wood

Dr. Michael B. Wood is Independent Director of the Company, since October 2004, and from August 2004 to the present a consultant orthopedic surgeon at the Mayo Clinic in Jacksonville, Florida and a Professor of Orthopedics at the Mayo Clinic College of Medicine. Dr. Wood served as President Emeritus of the Mayo Clinic Foundation from February 2003 until February 2004, and President and Chief Executive Officer of the Mayo Clinic Foundation from 1999 to 2003. The Mayo Clinic Foundation is a charitable, not-for-profit organization based in Rochester, Minnesota, and is the parent corporate entity of the Mayo Clinics in Minnesota, Florida and Arizona. Dr. Wood served as a director of Cubist Pharmaceuticals, Inc. until June 2014.

Julie Winter